All In MedTech

Device Trial Radar · NCT05757505

The Efficacy and Safety of Intracranial Stent (Tonbridge) in Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis

The Efficacy and Safety of the Intracranial Stent (Tonbridge) in Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis: A Prospective, Multicenter, Randomized Controlled, Non-inferiority Trial

Last checked: Nov 20, 2026Latest source record: Jan 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

May 11, 2023

Primary completion

Jan 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Ton-Bridge Medical Tech. Co., LtdNot on our public-company list
Sponsor type
Industry
First posted
Mar 7, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to verify the efficacy and safety of the Intracranial Stent (Tonbridge) in endovascular treatment of symptomatic intracranial atherosclerotic stenosis.

Conditions

  • Intracranial Atherosclerosis

Interventions

  • Intracranial Stent (Tonbridge)Device

    Endovascular treatment with Intracranial Stent (Tonbridge).

  • Wingspan Stent System (Stryker Neurovascular)Device

    Endovascular treatment with Wingspan Stent System (Stryker Neurovascular).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of any stroke and death within 30 daysTime frame: 30±7 days post-procedure

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • Changhai Hospital of Shanghai

    Shanghai, China · Not yet recruiting

12 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.